Jőrg‐Peter Kleim

1.5k total citations
17 papers, 849 citations indexed

About

Jőrg‐Peter Kleim is a scholar working on Infectious Diseases, Virology and Hepatology. According to data from OpenAlex, Jőrg‐Peter Kleim has authored 17 papers receiving a total of 849 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 11 papers in Virology and 4 papers in Hepatology. Recurrent topics in Jőrg‐Peter Kleim's work include HIV/AIDS drug development and treatment (12 papers), HIV Research and Treatment (11 papers) and HIV/AIDS Research and Interventions (4 papers). Jőrg‐Peter Kleim is often cited by papers focused on HIV/AIDS drug development and treatment (12 papers), HIV Research and Treatment (11 papers) and HIV/AIDS Research and Interventions (4 papers). Jőrg‐Peter Kleim collaborates with scholars based in United Kingdom, United States and Belgium. Jőrg‐Peter Kleim's co-authors include Margaret Tisdale, Stephan Duparc, Jörg J. Möhrle, Erik De Clercq, Justin A. Green, Michael Maguire, Ronnatrai Rueangweerayut, Philip Griffin, Paul A. J. Janssen and Y. Hsiou and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Molecular Biology.

In The Last Decade

Jőrg‐Peter Kleim

17 papers receiving 828 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jőrg‐Peter Kleim United Kingdom	12	488	433	205	137	101	17	849
Becky Chandler United Kingdom	13	382 0.8×	218 0.5×	45 0.2×	89 0.6×	186 1.8×	16	659
Caroline E. Ridgway United Kingdom	12	948 1.9×	1.0k 2.3×	131 0.6×	180 1.3×	59 0.6×	12	1.4k
Jennifer E. Vela United States	17	931 1.9×	367 0.8×	44 0.2×	317 2.3×	109 1.1×	19	1.2k
Mary J. Connell United States	15	304 0.6×	333 0.8×	111 0.5×	341 2.5×	10 0.1×	32	1.0k
Pascale Dehertogh Belgium	16	601 1.2×	363 0.8×	21 0.1×	183 1.3×	53 0.5×	19	1.1k
Ilaria Vicenti Italy	19	670 1.4×	276 0.6×	140 0.7×	123 0.9×	8 0.1×	75	943
Andrew Mulato United States	22	1.6k 3.2×	1.2k 2.8×	38 0.2×	315 2.3×	120 1.2×	33	2.1k
James P. Lavelle United States	11	438 0.9×	189 0.4×	49 0.2×	42 0.3×	20 0.2×	14	732
Trevor R. Scott United States	10	342 0.7×	257 0.6×	75 0.4×	41 0.3×	51 0.5×	12	615
Agnes I. Veldkamp Netherlands	17	697 1.4×	510 1.2×	83 0.4×	61 0.4×	140 1.4×	27	943

Countries citing papers authored by Jőrg‐Peter Kleim

Since Specialization

Citations

This map shows the geographic impact of Jőrg‐Peter Kleim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jőrg‐Peter Kleim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jőrg‐Peter Kleim more than expected).

Fields of papers citing papers by Jőrg‐Peter Kleim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jőrg‐Peter Kleim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jőrg‐Peter Kleim. The network helps show where Jőrg‐Peter Kleim may publish in the future.

Co-authorship network of co-authors of Jőrg‐Peter Kleim

This figure shows the co-authorship network connecting the top 25 collaborators of Jőrg‐Peter Kleim. A scholar is included among the top collaborators of Jőrg‐Peter Kleim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jőrg‐Peter Kleim. Jőrg‐Peter Kleim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

1.

Rueangweerayut, Ronnatrai, Germana Bancone, Andrew P. Beelen, et al.. (2017). Hemolytic Potential of Tafenoquine in Female Volunteers Heterozygous for Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency (G6PD Mahidol Variant) versus G6PD-Normal Volunteers. American Journal of Tropical Medicine and Hygiene. 97(3). 702–711. 72 indexed citations

2.

Llanos‐Cuentas, Alejandro, Marcus Lacerda, Ronnatrai Rueangweerayut, et al.. (2013). Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study. The Lancet. 383(9922). 1049–1058. 180 indexed citations

3.

Miller, Ann K., Ye Li, Jőrg‐Peter Kleim, et al.. (2013). Pharmacokinetic interactions and safety evaluations of coadministered tafenoquine and chloroquine in healthy subjects. British Journal of Clinical Pharmacology. 76(6). 858–867. 36 indexed citations

4.

Ren, Jingshan, Charles E. Nichols, Philip P. Chamberlain, et al.. (2007). Relationship of Potency and Resilience to Drug Resistant Mutations for GW420867X Revealed by Crystal Structures of Inhibitor Complexes for Wild-Type, Leu100Ile, Lys101Glu, and Tyr188Cys Mutant HIV-1 Reverse Transcriptases. Journal of Medicinal Chemistry. 50(10). 2301–2309. 55 indexed citations

5.

Maguire, Michael, Rosario Guinea, Philip Griffin, et al.. (2002). Changes in Human Immunodeficiency Virus Type 1 Gag at Positions L449 and P453 Are Linked to I50V Protease Mutants In Vivo and Cause Reduction of Sensitivity to Amprenavir and Improved Viral Fitness In Vitro. Journal of Virology. 76(15). 7398–7406. 117 indexed citations

6.

Kleim, Jőrg‐Peter, et al.. (2002). Inclusion of full length human immunodeficiency virus type 1 (HIV-1) gag sequences in viral recombinants applied to drug susceptibility phenotyping. Journal of Virological Methods. 104(2). 147–160. 11 indexed citations

7.

Laethem, Kristel Van, Myriam Witvrouw, Christophe Pannecouque, et al.. (2001). Mutations in the non-nucleoside binding-pocket interfere with the multi-nucleoside resistance phenotype. AIDS. 15(5). 553–561. 16 indexed citations

8.

Hsiou, Y., Kalyan Das, Arthur D. Clark, et al.. (2001). The Lys103Asn mutation of HIV-1 RT: a novel mechanism of drug resistance. Journal of Molecular Biology. 309(2). 437–445. 147 indexed citations

9.

Arastéh, Keikawus, Robin Wood, Markus Müller, et al.. (2001). GW420867X Administered to HIV-1-Infected Patients Alone and in Combination with Lamivudine and Zidovudine. HIV Clinical Trials. 2(4). 307–316. 11 indexed citations

10.

Balzarini, Jan, et al.. (2000). Long-Term Exposure of HIV Type 1-Infected Cell Cultures to Combinations of the Novel Quinoxaline GW420867X with Lamivudine, Abacavir, and a Variety of Nonnucleoside Reverse Transcriptase Inhibitors. AIDS Research and Human Retroviruses. 16(6). 517–528. 43 indexed citations

11.

Maguire, Michael, Martin Gartland, Sarah Moore, et al.. (2000). Absence of zidovudine resistance in antiretroviral-naive patients following zidovudine/lamivudine/protease inhibitor combination therapy: virological evaluation of the AVANTI 2 and AVANTI 3 studies. AIDS. 14(9). 1195–1201. 63 indexed citations

12.

Ait‐Khaled, Mounir, et al.. (1999). A Novel Genotype Encoding a Single Amino Acid Insertion and Five Other Substitutions Between Residues 64 and 74 of the HIV-1 Reverse Transcriptase Confers High-Level Cross-Resistance to Nucleoside Reverse Transcriptase Inhibitors. JAIDS Journal of Acquired Immune Deficiency Syndromes. 22(2). 139–139. 19 indexed citations

13.

Kleim, Jőrg‐Peter, et al.. (1999). Antiviral Activity of the Human Immunodeficiency Virus Type 1–Specific Nonnucleoside Reverse Transcriptase Inhibitor HBY 097 Alone and in Combination with Zidovudine in a Phase II Study. The Journal of Infectious Diseases. 179(3). 709–713. 11 indexed citations

14.

Ait‐Khaled, Mounir, et al.. (1999). A Novel Genotype Encoding a Single Amino Acid Insertion and Five Other Substitutions Between Residues 64 and 74 of the HIV-1 Reverse Transcriptase Confers High-Level Cross-Resistance to Nucleoside Reverse Transcriptase Inhibitors. JAIDS Journal of Acquired Immune Deficiency Syndromes. 22(2). 139–139. 20 indexed citations

15.

Prinzinger, Roland, Jőrg‐Peter Kleim, Werner Schroth, & Bernd Schierwater. (1997). DNA sequence analysis of mitochondrial Cyt-b and the species status ofLaniarius dubiosus (Rchw. 1899). Journal für Ornithologie. 138(3). 291–296. 7 indexed citations

16.

Prinzinger, Roland, Peter Becker, Jőrg‐Peter Kleim, Werner Schroth, & Bernd Schierwater. (1997). Der taxonomische Status vonLaniarius dubiosus (Rchw. 1899) mit ergänzenden Daten zur Typusbeschreibung vonLaniarius liberatus, Bulo Burti Boubou (Smith, Arctander, Fjeldså & Amir 1991). Journal für Ornithologie. 138(3). 283–289. 2 indexed citations

17.

Balzarini, Jan, Heidi Pelemans, Anna Karlsson, Erik De Clercq, & Jőrg‐Peter Kleim. (1996). Concomitant combination therapy for HIV infection preferable over sequential therapy with 3TC and non-nucleoside reverse transcriptase inhibitors. Proceedings of the National Academy of Sciences. 93(23). 13152–13157. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact